Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jul 16, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Policy Notices
- Requirement for ORCID iDs for Individuals Supported by Research Training, Fellowship, Research Education, and Career Development Awards Beginning in FY 2020
National Institutes of Health
- Reminders of NIH Policies on Other Support and on Policies related to Financial Conflicts of Interest and Foreign Components
National Institutes of Health
General Notices
- Notice of New NIH-Designated Data Repository: NHGRIs Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL)
National Human Genome Research Institute
- Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for RFA-OD-19-021 "Maximizing the Scientific Value of Existing Biospecimen Collections" and RFA-OD-19-022 "Secondary Analyses of Existing Datasets of Tobacco Use and Health"
Office of Disease Prevention
- Request for Information (RFI): Guidance on Current Education Curricula for Health Care Professionals Regarding Pain and Opioid Misuse and Use Disorder
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Notice of Changes to Funding Opportunities
- Notice of Change to RFA-AG-20-024 "Science of Behavior Change (SOBC) Resource and Coordinating Center (U24 Clinical Trial Not Allowed"
National Institute on Aging
- Notice of Change to NOT-AG-19-017 "Request for Information (RFI): Inviting comments and suggestions for the development of the NIA Longitudinal Rat Resource to study neural and behavioral trajectories of successful cognitive aging"
National Institute on Aging
- Notice of Correction RFA-DA-20-008, "Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)"
National Institute on Drug Abuse
- Notice of Clarification to Institutional Eligibility and Correction to the Cap for Training Related Expenses in PAR-19-299 "Bridges to the Baccalaureate Research Training Program (T34)"
National Institute of General Medical Sciences
- Notice of Clarification of Institutional and Program Director/Principal Investigator Eligibility for PAR-19-037 Initiative for Maximizing Student Development (IMSD) (T32)
National Institute of General Medical Sciences
- Notice of Change to HEAL Initiative: Announcement of Collaboration Opportunities for Developing Drugs and Human Cell-Based Testing Platforms for Pain, Addiction and Overdose (NOT-TR-19-018)
National Center for Advancing Translational Sciences
- Notice of Change to NOT-TR-19-014: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions
John E. Fogarty International Center
Requests for Proposal
- HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2020-1) Now Available
National Institutes of Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03)
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21)
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Biosensors to Detect Exacerbations of Cardiopulmonary Disease
National Heart, Lung, and Blood Institute
Funding Opportunities
- Mechanisms of Tolerance (R21/R33 - Clinical Trial Required)
(PAR-19-311)
National Institute on Alcohol Abuse and Alcoholism
- Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
National Institute of General Medical Sciences
- NIA Program Project Applications (P01 Clinical Trial Optional)
National Institute on Aging
- Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Specialized Alcohol Research Centers (P50 Clinical trial Optional)
- Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
- Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed)
- Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed)
National Institute on Drug Abuse
- Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)
National Institute on Drug Abuse
- Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
- Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
- Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu